Funding
With $20B Raised Globally in the First Half of 2021, Health Innovation Funding Shows (More) Record Growth Post COVID
Funding announcements in health innovation have been coming in hot and fast these days.
Bob Teague
July 28, 2021
Funding announcements in health innovation have been coming in hot and fast these days.
by Bob Teague
Let’s say you have the most amazing technical solution for healthcare in history.
Providing broad access to virtual care seems like an obvious thing to do. And it looks like CMS is at least considering this expansion. The Cartel is mighty, however, and the pushback could be great. The market seems to agree and is not very enthusiastic at the prospects of these firms.
H1 2021 secured $14.7B in digital health funding, already surpassing all of 2020’s funding. The half closed with 372 deals and an average deal size of $39.6M, spearheaded by 48 mega deals which accounted for 59% of total H1 2021 funding. Public exit activity ballooned with 11 closed IPOs and SPACs, with another 11 SPACs expected to close in 2021.
A new CRISPR-based treatment for a rare, deadly liver disease depends on an injection containing both a messenger RNA encoding a DNA-cutting enzyme (white) and another RNA (blue) that guides it to a specific gene sequence (green).
Organizing healthcare products and services into three categories including biotech complex, information dependent services, and consumer and patient experience and self-care may help track performance and relative valuation. In the end, whether new tech brings clinical value is the open question.
Digital health has been setting records for raising money in the private markets through VC’s and other sources of private investment. The hype is enormous for unproven technologies. The dynamics in the public markets for digital health stocks, the few that exist, hasn’t been so consistently enthusiastic. This will sort itself out based on delivering of actual value to patients, consumers and shareholders.
This market is as bullish and as overbought as it has been in a couple of decades though the monetary and fiscal backdrop are much different now. The huge money is rotating this way and that as we continue to slosh the bull.
2021 opened with a whirlwind of SPAC-triggered public exit activity in digital health. In this post, we share insights and analysis on how digital health’s SPAC boom will impact four different stakeholder groups, as well as implications for the entire ecosystem.
2021 opened with a whirlwind of SPAC-triggered public exit activity in digital health. In this post, we share insights and analysis on how digital health’s SPAC boom will impact four different stakeholder groups, as well as implications for the entire ecosystem.
PO Box 637
Austin, Texas
[email protected]
By providing your contact information you consent to receiving emails & information from Green Room Technologies.
No Spam. We respect your privacy & you may unsubscribe at any time.